Results of treatment with tamsulosin in men with acute urinary retention

Techniques in Urology

Volumn 7, Issue 4, 2001, Pages 256-260

  Kim, H L ^a   Kim, J C ^a   Benson, D A ^a   Bales, G T ^a   Gerber, G S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Benign prostatic hyperplasia; Tamsulosin; Urinary retention

Indexed keywords

TAMSULOSIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; FOLLOW UP; HUMAN; INTERMITTENT CATHETERIZATION; MALE; MICTURITION DISORDER; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RESIDUAL VOLUME; SCORING SYSTEM; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINE CATHETER; URINE RETENTION; URODYNAMICS;

ACUTE DISEASE; ADRENERGIC ALPHA-ANTAGONISTS; AGED; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SULFONAMIDES; TREATMENT OUTCOME; URINARY CATHETERIZATION; URINARY RETENTION;

EID: 0035191295     PISSN: 10793259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. The development of human benign prostatic hyperplasia with age
2. The role of communitybased longitudinal studies in evaluating treatment effects. Example: Benign prostatic hyperplasia
3. Benign prostatic hyperplasia: Diagnosis and treatment
4. Serum prostatespecific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia
5. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia
6. Trial without catheter following acute retention of urine
7. Sustained-release alfuzosin and trial without catheter after acute urinary retention: A prospective, placebo-controlled
8. High-energy transurethral microwave thermotherapy in patients with acute urinary retention due to benign prostatic hyperplasia
9. Long-term evaluation of tamsulosin in benign prostatic hyperplasia: Placebo-controlled, double-blind extension of phase III trial
10. Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia
11. Tamsulosin: 3-Year longterm efficacy and safety in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction: Analysis of a European, multinational, multicenter, open-label study
12. Incidence rates and risk factors for acute urinary retention: The health professionals followup study
13. Acute urinary retention - A urodynamic assessment